Accelerate Diagnostics, Inc. (AXDX)의 가격은 얼마입니까?

Accelerate Diagnostics, Inc. (AXDX)의 가격은 $0.01005입니다.

Accelerate Diagnostics, Inc. (AXDX)의 시가 총액은 무엇입니까?

Accelerate Diagnostics, Inc. (AXDX)의 시가 총액은 $146.42K입니다.

Accelerate Diagnostics, Inc. (AXDX) PER

Accelerate Diagnostics, Inc. is an in vitro diagnostics company specializing in solutions for the rapid diagnosis of critical infections, with operations spanning the United States, Europe, and the Middle East. The company's primary offering is the Accelerate Pheno system, an advanced in vitro diagnostic platform. Paired with its dedicated test kit, the Accelerate PhenoTest, this system facilitates quick identification and antimicrobial susceptibility testing (AST) for pathogens responsible for severe or healthcare-associated infections, encompassing both Gram-positive and Gram-negative organisms. The PhenoTest is specifically designed to yield crucial ID and AST results for patients suspected of bacteremia or fungemia – life-threatening conditions marked by high morbidity and mortality risks. Established in 1982, the company initially operated as Accelr8 Technology Corporation before adopting its current name, Accelerate Diagnostics, Inc., in December 2012. Its corporate headquarters are located in Tucson, Arizona.

연도	P/E 비율	변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.

연도

P/E 비율

변화

제공된 날짜에 대한 데이터가 충분하지 않습니다.

회사	P/E 비율	P/E 비율 차이	국가
Abbott Laboratories ABT.US	33.99	-	US
Stryker Corporation SYK.US	33.47	-	US
Medtronic plc MDT.US	21.39	-	IE
Boston Scientific Corporation BSX.US	18.84	-	US
Edwards Lifesciences Corporation EW.US	49.47	-	US

회사

P/E 비율

P/E 비율 차이

국가